LexisNexis® Legal Newsroom
N.H. Jury Awards $21 Million To Woman Claiming Pain Medication Caused Blindness

CONCORD, N.H. - (Mealey's) A federal jury in New Hampshire on Sept. 8 awarded $21 million to a woman who claims that her use of a generic version of the nonsteroidal anti-inflammatory drug Clinoril caused her to suffer Stevens-Johnson syndrome (SJS), which led to permanent injuries, including blindness...

1st Circuit: $21 Million Design Defect Verdict For Generic Drug Injury Not Preempted

BOSTON - (Mealey's) A panel of the First Circuit U.S. Court of Appeals on May 2 affirmed a $21 million generic drug injury verdict, finding that a 2011 Supreme Court ruling about generic drug injury claims does not preempt design defect claims ( Karen L. Bartlett v. Mutual Pharmaceutical Company...